Clinical trial NCT02352428: Skin Cancer Screening Education Study
Official title: Skin Cancer Screening Education Study
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Skin Tumors
Melanoma
Basal Cell Carcinoma
Squamous Cell Carcinoma
Keywords: Skin Cancer
Secondary Prevention
Population Screening
Lead sponsor: Association of Dermatological Prevention, Germany
Sponsor class: OTHER
Collaborators: name: University of Calgary
name: University of Alberta
First posted: 2015-02-02
Enrollment: 113
Sex: ALL
Minimum age (years): 20
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SCREENING

Brief summary: The overall aim of this population-based screening study is to assess whether the skin cancer screening training of family physicians and dermatologists leads to improved screening outcomes. The training course aims to increase the accuracy of detecting early stages of skin cancer. Screening outcomes of an intervention region (Calgary, Canada) in which physicians receive training will be compared with screening outcomes of a control region (Edmonton, Canada) where no physician training is administered.

The investigators will determine whether:

* clinical screening outcomes are more favorable in the group of trained physicians compared to non trained physicians
* there is an increase of knowledge about skin cancer screening among trained physicians, compared to non trained physicians
* skin cancer screenings are associated with psycho-social harms
* population-based screening has an effect on the overall incidence and stage-specific-incidence of skin cancer in Alberta

The investigators are aiming to recruit 100 physicians per region (total of 200 physicians) who will screen 40,000 to 80,000 individuals over a period of 20 months.


Eligibility criteria: Inclusion Criteria:

1. Screenees

   * Male and female residents of Alberta mainly living and receiving care in Edmonton or in Calgary
   * Age 20+
   * English-speaking
   * Individuals who consent to participate
2. Physicians

   * Registered dermatologists and family physicians administering care either in Edmonton or in Calgary
   * English-speaking
   * Physicians who consent to participate

Exclusion Criteria:

Physicians who have undergone special training in skin cancer screening within the last 2 years

Primary outcomes:
measure: Change in the diagnostic accuracy including knowledge on skin cancer screening
timeFrame: month 1 pre-training (intervention and control region), month 1 post-training (intervention region only), and month 12 (both regions)
measure: Number needed to screen (NNS) to identify 1 skin tumor and number needed to excise (NNE) to identify 1 skin tumor
timeFrame: 20 months
measure: Patient-rated well-being
timeFrame: 20 months
measure: Trends of overall skin cancer incidence and stage-specific-incidence
timeFrame: Up to 6 years (2012-2018)
Secondary outcomes:
Other outcomes:
Locations:
city: Calgary, Edmonton
country: Canada
facility: University of Calgary, University of Alberta
state: Alberta
Study officials:
affiliation: University of Calgary
name: Lynne H Robertson, MD, FRCPC
role: PRINCIPAL_INVESTIGATOR
affiliation: University of Alberta
name: Gordon E Searles, MD, FRCPC
role: PRINCIPAL_INVESTIGATOR
affiliation: Association of Dermatological Prevention, Germany
name: Eckhard W Breitbart, MD, PhD
role: PRINCIPAL_INVESTIGATOR
References: